Joshua Dennerlein
Stock Analyst at B of A Securities
(2.13)
# 2,739
Out of 4,711 analysts
87
Total ratings
42.37%
Success rate
-5.62%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $123.68 | -7.83% | 2 | Nov 12, 2024 | |
| FVR FrontView REIT | Initiates: Buy | $22 | $18.23 | +20.68% | 1 | Oct 28, 2024 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $30.55 | +11.29% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $27.75 | +11.71% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $69.85 | +31.71% | 1 | Sep 24, 2024 | |
| ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $283.76 | +13.12% | 3 | Sep 24, 2024 | |
| LINE Lineage | Initiates: Buy | $100 | $58.57 | +70.74% | 1 | Aug 19, 2024 | |
| CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $114.91 | +27.93% | 4 | Aug 12, 2024 | |
| MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $153.40 | +23.21% | 3 | Aug 12, 2024 | |
| EPR EPR Properties | Downgrades: Underperform | $45 → $40 | $43.59 | -8.24% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $20.12 | +24.25% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $37.83 | -18.05% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $58.76 | -9.80% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $10.05 | -40.30% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $43.46 | -24.07% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $14.16 | +5.93% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $52.79 | -1.50% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $16.96 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $54.25 | -0.46% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $3.86 | +107.25% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $11.38 | +137.26% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $21.48 | +55.96% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.53 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $70.17 | +11.16% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $40.35 | +16.48% | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $73 → $78 | $124.64 | -37.42% | 5 | Mar 30, 2021 |
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $123.68
Upside: -7.83%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $18.23
Upside: +20.68%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $30.55
Upside: +11.29%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $27.75
Upside: +11.71%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $69.85
Upside: +31.71%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $283.76
Upside: +13.12%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $58.57
Upside: +70.74%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $114.91
Upside: +27.93%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $153.40
Upside: +23.21%
EPR Properties
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $43.59
Upside: -8.24%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $20.12
Upside: +24.25%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $37.83
Upside: -18.05%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $58.76
Upside: -9.80%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $10.05
Upside: -40.30%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $43.46
Upside: -24.07%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $14.16
Upside: +5.93%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $52.79
Upside: -1.50%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $16.96
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $54.25
Upside: -0.46%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $3.86
Upside: +107.25%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $11.38
Upside: +137.26%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $21.48
Upside: +55.96%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.53
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $70.17
Upside: +11.16%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $40.35
Upside: +16.48%
Mar 30, 2021
Upgrades: Buy
Price Target: $73 → $78
Current: $124.64
Upside: -37.42%